PDCD1 and neoplasm: In a recent case report, extreme activation of a PAL of PD-1 signaling cascade along with the high tumor infiltration by T-cells was a main reason to successfully prescribe off-label PD-1 specific immunotherapy to a IV stage chemoresistant gastric cancer patient (26).